Professor Brenda Gannon is a Professor of Health Economics at the Centre for the Business and Economics of Health, The University of Queensland.
Brenda is an international expert in the field of health and aging economics and health econometrics and has won over $21 million, as chief investigator, in collaborative research income with economics, medicine and social science with academia and industry. Her research carries a dual role, (1) as a methodologist (applied health economist and econometrician using big and complex data), utilising health economics theory and concepts to test the validity of causal hypotheses, (2) collaborator across all Faculties leading critical economic evaluations.
Brenda’s research is funded by her position as chief investigator on projects from the Australian Research Council Discovery Grant and NHMRC Boosting Dementia grants. She is the lead economist on two major new Randomised Control Trials in dementia and emergency care, funded by EU H2020 and Health Research Board Ireland, Feasibility Trials in falls funded by EU H2020, phase 1 trial research in diabetes with Mater Research Institute, UQ, economics of genetics funding by QGHA, and economics of stroke funded by NIHR HS&DR. All studies incorporate methodological innovations and applied research.
Previously she was an associate professor at The University of Manchester and University of Leeds from 2011-2016. Prior to that she was a senior research officer and deputy director at the Irish Centre for Social Gerontology/Department of Economics at the National University of Ireland, Galway and researcher at the Economic and Social Research Institute, Dublin, Ireland, under the Health Research Ireland, Health Economics and Inequalities programme of research.
Brenda is currently an Expert Evaluator for the EU Commission funding applications and recently a member of the UK National Institute for Health Research RfPB (Research for Patient Benefit) Advisory Committee.